Globus Lucidus: A porcine study of an intracranial implant designed to deliver closed, repetitive photodynamic and photochemical therapy in glioblastoma.

glioblastoma intracerebral implant repetitive photochemical therapy repetitive photodynamic therapy

Journal

Photodiagnosis and photodynamic therapy
ISSN: 1873-1597
Titre abrégé: Photodiagnosis Photodyn Ther
Pays: Netherlands
ID NLM: 101226123

Informations de publication

Date de publication:
26 Mar 2024
Historique:
received: 08 01 2024
revised: 18 03 2024
accepted: 20 03 2024
medline: 29 3 2024
pubmed: 29 3 2024
entrez: 28 3 2024
Statut: aheadofprint

Résumé

Herein we describe initial results in a porcine model of a fully implantable device designed to allow closed, repetitive photodynamic treatment of glioblastoma (GBM). This implant, Globus Lucidus, is a transparent quartz glass sphere with light-emitting diodes releasing wavelengths of 630 nm (19.5 mW/cm Surgery, implants, and repeated irradiations using the different wavelengths were generally well tolerated. Social behavior, wound healing, body weight, and temperature remained unaffected. Histopathological analyses revealed consistent leukocyte infiltration around the intracerebral implant sites with no significant differences between experimental and control groups. This Globus Lucidus porcine study prepares the groundwork for adjuvant, long-term, repeated PDT of the GBM infiltration zone. This is the first report of a fully implantable PDT/PCT device for the potential treatment of GBM. A preclinical effectivity study of Globus Lucidus PDT/PCT is warranted and in advanced stages of planning.

Identifiants

pubmed: 38548041
pii: S1572-1000(24)00098-X
doi: 10.1016/j.pdpdt.2024.104059
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104059

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The funders had no role in the study design, analyses, data interpretation, writing, or decision to publish.

Auteurs

Nicolas Bader (N)

Biomechatronics Research Group, Ulm University of Applied Sciences, Ulm, Germany.

Christian Peschmann (C)

Department of Anesthesiology and Intensive Care, Ulm University Medical Center, Ulm, Germany.

Richard Eric Kast (RE)

IIAIGC Study Center, Burlington, VT, U.S.A.

Tim Heiland (T)

Spine Center Bodensee, Meckenbeuren, Germany.

Tamara Merz (T)

Institute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Ulm, Germany.

Oscar McCook (O)

Institute for Anesthesiological Pathophysiology and Process Engineering, Ulm University Medical Center, Ulm, Germany.

Alex Alfieri (A)

Department of Neurosurgery, Cantonal Hospital of Winterthur, Winterthur, Switzerland; Advanced Treatment Concepts against Glioblastoma (ATCG), Kreuzlingen, Switzerland.

Georg Karpel-Massler (G)

Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany.

Felix Capanni (F)

Biomechatronics Research Group, Ulm University of Applied Sciences, Ulm, Germany.

Marc-Eric Halatsch (ME)

Department of Neurosurgery, Cantonal Hospital of Winterthur, Winterthur, Switzerland; Advanced Treatment Concepts against Glioblastoma (ATCG), Kreuzlingen, Switzerland. Electronic address: Marc-Eric.Halatsch@ksw.ch.

Classifications MeSH